YouTube

Monster Energy Riders Sweep Podium in Vans Showdown Street Skateboarding Competition and Peraza Wins Vans BMX Waffle Cup Competition During the Vans US Open

Retrieved on: 
Tuesday, August 9, 2022 - 1:15am

HUNTINGTON BEACH, Calif., Aug. 8, 2022 /PRNewswire-PRWeb/ -- A huge weekend for action sports! Monster Energy congratulates team rider Kevin Peraza on taking first place in the Vans BMX Waffle Cup street competition at the U.S. Open of Surfing in Huntington Beach this weekend. In the pro BMX street contest, the 27-year-old from Tucson, Arizona, rose all the way to the top of the leaderboard with a flawless technical run.

Key Points: 
  • Monster Energy congratulates team rider Kevin Peraza on taking first place in the Vans BMX Waffle Cup street competition at the U.S. Open of Surfing in Huntington Beach this weekend.
  • In Sunday's Vans Showdown street skateboarding competition, Monster Energy riders swept the entire podium: 25-year-old Colombian team rider Jhancarlos Gonzalez took first place in the jam session final.
  • In Friday's Vans BMX Waffle Cup street final, a roster of international top professionals took on the technical street course.
  • In Sunday's Vans Showdown street skateboarding contest, qualified riders took on the street course in several jam sessions featuring three riders at a time.

Root, Inc. Announces 2022 Second Quarter Results; Moving Forward with Reverse Stock Split at 1-for-18 Ratio

Retrieved on: 
Monday, August 8, 2022 - 9:17pm

Roots second quarter results and management commentary can be found by accessing the shareholder letter posted to the companys investor relations website at ir.joinroot.com .

Key Points: 
  • Roots second quarter results and management commentary can be found by accessing the shareholder letter posted to the companys investor relations website at ir.joinroot.com .
  • Webcast and Conference Call Details:
    Additionally, Root announced today that it will proceed with a 1-for-18 reverse stock split previously approved by Root stockholders at the annual meeting of shareholders on June 7, 2022.
  • No fractional shares will be issued in connection with the reverse stock split.
  • Additional information concerning the reverse stock split can be found in Roots definitive proxy statement filed with the Securities and Exchange Commission on April 28, 2022.

Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results

Retrieved on: 
Monday, August 8, 2022 - 9:05pm

SOUTH SAN FRANCISCO, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today provided a corporate update and reported second quarter 2022 financial results.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today provided a corporate update and reported second quarter 2022 financial results.
  • A highlight to our teams progress in 2022 is the positive safety and efficacy data from the INTEGRIS-IPF Phase 2a trial.
  • Pliant Therapeutics is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis.
  • For additional information about Pliant Therapeutics, visit www.pliantrx.com and follow us on Twitter, LinkedIn, Facebook and YouTube.

Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15

Retrieved on: 
Monday, August 8, 2022 - 9:45pm

The randomized, placebo-controlled, Phase 3 VALOR study is planned to enroll approximately 6,000 participants 5 years of age and older.

Key Points: 
  • The randomized, placebo-controlled, Phase 3 VALOR study is planned to enroll approximately 6,000 participants 5 years of age and older.
  • As per the terms of the collaboration agreement between Pfizer and Valneva, Pfizer will make a $25 million milestone payment to Valneva upon initiation of the Phase 3 study.
  • VLA15 is the only Lyme disease vaccine candidate currently in clinical development.
  • This investigational multivalent protein subunit vaccine uses an established mechanism of action for a Lyme disease vaccine that targets the outer surface protein A (OspA) of Borrelia burgdorferi, the bacteria that cause Lyme disease.

PagerDuty to Present at the Canaccord Genuity 42nd Annual Growth Conference

Retrieved on: 
Monday, August 8, 2022 - 9:05pm

PagerDuty, Inc. (NYSE:PD), a global leader in digital operations management, today announced that members of its management team will present at the Canaccord Genuity 42nd Annual Growth Conference on Wednesday, August 10th, at 3:00 p.m.

Key Points: 
  • PagerDuty, Inc. (NYSE:PD), a global leader in digital operations management, today announced that members of its management team will present at the Canaccord Genuity 42nd Annual Growth Conference on Wednesday, August 10th, at 3:00 p.m.
  • PagerDuty, Inc. (NYSE:PD) is a leader in digital operations management.
  • In an always-on world, organizations of all sizes trust PagerDuty to help them deliver a perfect digital experience to their customers, every time.
  • Teams use PagerDuty to identify issues and opportunities in real time and bring together the right people to fix problems faster and prevent them in the future.

Viasat Releases First Quarter Fiscal Year 2023 Financial Results

Retrieved on: 
Monday, August 8, 2022 - 9:05pm

CARLSBAD, Calif., Aug. 8, 2022 /PRNewswire/ -- Viasat Inc. (NASDAQ: VSAT), a global leader in satellite communications, today published its first quarter fiscal year 2023 financial results in a letter to shareholders, which is now posted to the Investor Relations section of the website.

Key Points: 
  • CARLSBAD, Calif., Aug. 8, 2022 /PRNewswire/ -- Viasat Inc. (NASDAQ: VSAT), a global leader in satellite communications, today published its first quarter fiscal year 2023 financial results in a letter to shareholders, which is now posted to the Investor Relations section of the website.
  • As previously announced, the company will host a conference call today, August 8, 2022, at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time.
  • The dial in numbers for the conference are (U.S.) (646) 307-1963 and (International) (800) 715-9871.
  • The call will be archived and available on the site for approximately one month immediately following the conference call.

Xenia Kovacs joins growing ECG Core Lab provider, HeartcoR Solutions, as associate director of clinical project management

Retrieved on: 
Monday, August 8, 2022 - 7:30pm

SCHAUMBURG, Ill., Aug. 8, 2022 /PRNewswire-PRWeb/ -- HeartcoR Solutions, a leading ECG Core Lab provider that delivers 'round the clock clinical research for cardiac safety studies to pharmaceutical, medical device, and CROs worldwide, announced today that Xenia Kovacs has joined the organization as associate director of project management.

Key Points: 
  • Kovacs will lead clinical project management team that is currently handling multiple studies globally while overseeing recruitment, training, and performance of project management staff
    SCHAUMBURG, Ill., Aug. 8, 2022 /PRNewswire-PRWeb/ -- HeartcoR Solutions , a leading ECG Core Lab provider that delivers 'round the clock clinical research for cardiac safety studies to pharmaceutical, medical device, and CROs worldwide, announced today that Xenia Kovacs has joined the organization as associate director of project management.
  • In her new role, she will provide leadership to HeartcoR's project teams, while overseeing project management recruitment to accommodate an increase in the number and size of clinical trials HeartcoR is managing.
  • Prior to joining HeartcoR, Kovacs served in senior clinical project management roles for Abbott Molecular, Abbott/AbbVie, and Pfizer.
  • is a leading-edge ECG Core Lab providing 24/7 research and clinical trial management services to pharma, medical device and biotech companies worldwide.

EXolo Aims To Impress The Crypto Community By Providing High Quality Spot And Futures Trading Capabilities

Retrieved on: 
Monday, August 8, 2022 - 6:35pm

Secondly, when it comes to security, EXolo has implemented 2FA (two-factor authentication) which helps customers stay safe since this measure deters hackers and viruses.

Key Points: 
  • Secondly, when it comes to security, EXolo has implemented 2FA (two-factor authentication) which helps customers stay safe since this measure deters hackers and viruses.
  • Moreover, EXolo offers up to 10x leverage and 40 perpetual contracts for futures trading, which is among the most popular types of cryptocurrency trading nowadays.
  • Additionally, all bonuses are only available for the futures trading market and will be deposited directly into USDT wallet addresses of EXolo users.
  • EXolo was launched earlier this year and offers an easy-to-use platform which supports numerous tokens along with providing both spot and futures trading capabilities.

Livento Group (NUGN) to Participate in Proactive’s Virtual One2One Investor Forum on August 9, 2022

Retrieved on: 
Monday, August 8, 2022 - 6:30pm

New York, NY, Aug. 08, 2022 (GLOBE NEWSWIRE) -- NuGene International, Inc./ Livento Group, Inc. (OTC Pink: NUGN) today announced it will participate in the upcoming Proactive One2One Investor Forum taking place virtually on August 9, 2022.

Key Points: 
  • New York, NY, Aug. 08, 2022 (GLOBE NEWSWIRE) -- NuGene International, Inc./ Livento Group, Inc. (OTC Pink: NUGN) today announced it will participate in the upcoming Proactive One2One Investor Forum taking place virtually on August 9, 2022.
  • Livento Group specializes in the identification and acquisition of companies and projects showing exceptional value and strong growth in their sector.
  • Our focus at Livento Group is to offer investors significant value, while minimizing risk, across each of our subsidiaries, stated tbr.
  • Its One2One Investor Forum will bring together leading growth companies with an audience of high-net-worth investors, fund managers, private client brokers and analysts.

Edge Autonomy Acquires Adaptive Energy, a Leader in Solid Oxide Fuel Cell Technology

Retrieved on: 
Monday, August 8, 2022 - 6:00pm

SAN LUIS OBISPO, Calif., Aug. 8, 2022 /PRNewswire/ -- Edge Autonomy, a leader in unmanned and autonomous technology, announced today that it has acquired Adaptive Energy (or "the Company"), a globally recognized designer and manufacturer of solid oxide fuel cells (SOFC) for backup, off grid and UAV power. Terms of the transaction were not disclosed.

Key Points: 
  • In addition, Adaptive Energy's lightweight, energy dense SOFC have been integrated as critical technology in Edge Autonomy's UAV platforms for more than 10 years.
  • Based in Ann Arbor, MI, Adaptive Energy's proprietary technology is based on 12 active patents that were developed by some of the world's foremost authorities in microtubular solid oxide fuel cell technology.
  • "Having used Adaptive Energy's SOFCs for years, we know first-hand the value the team will bring to Edge Autonomy and our customers," said John Purvis, CEO of Edge Autonomy.
  • Headquartered in San Luis Obispo, CA, Edge Autonomy is a leader in unmanned and autonomous technology.